Teijin Limited (3401.T) Bundle
Founded in 1918, Teijin Limited has grown into a Japanese multinational operating in over 20 countries with approximately 20,000 employees and a diversified portfolio-aramid fibers, carbon fibers, composites and healthcare solutions-that generated consolidated revenue of JPY 1,005.5 billion for the fiscal year ending March 31, 2025; guided by the mission 'Pioneering solutions together for a healthy planet' and the vision 'To be a company that supports the society of the future,' Teijin leverages its core values-empowering employees to address challenges, fostering growth through diversity and expertise, and safeguarding our planet-to drive innovation across mobility, infrastructure, industrial and healthcare sectors while committing to net-zero emissions by 2050, so explore how these strategic pillars translate into measurable impact and long-term resilience.
Teijin Limited (3401.T) - Intro
Teijin Limited, established in 1918, is a Japanese multinational specializing in high-performance materials and healthcare solutions. The company operates in over 20 countries with approximately 20,000 employees and reported consolidated revenue of JPY 1,005.5 billion for the fiscal year ending March 31, 2025. Teijin's product portfolio centers on aramid fibers, carbon fibers, composites, and a growing suite of healthcare solutions, serving mobility, infrastructure, industrial and healthcare sectors. The company has publicly committed to achieving net‑zero emissions by 2050 and pursues ESG integration across operations.- Established: 1918
- Global footprint: >20 countries
- Workforce: ~20,000 employees
- FY2025 consolidated revenue: JPY 1,005.5 billion
- Net‑zero target: 2050
Mission
Teijin's mission emphasizes innovation in materials and healthcare to enhance the safety, security and quality of life globally. Key mission drivers include advanced materials R&D, lifecycle value-chain solutions, and healthcare services that improve patient outcomes and reduce societal costs.- Deliver high-performance materials (aramid, carbon fibres, composites)
- Provide integrated healthcare solutions (pharmaceuticals, home healthcare)
- Enable sustainable mobility and infrastructure through lightweighting and durability
Vision
Teijin's vision is to be a global leader in advanced materials and healthcare, creating new value through circular solutions, digitalization and partnerships that accelerate decarbonization and resource efficiency.- Be a top provider of carbon- and aramid-based solutions for next‑gen mobility
- Expand healthcare services and preventive care platforms
- Scale circular economy initiatives across product lifecycles
Core Values
- Innovation - sustained investment in R&D to drive differentiated performance materials
- Integrity - compliance, safety and ethical business practices across ~20 countries
- Customer-centricity - co-creation with OEMs and healthcare partners
- Sustainability - net‑zero by 2050, resource-efficient manufacturing and recycling
- Social contribution - improving quality of life via healthcare and safety solutions
Business Segments & Strategic Focus
- Performance Materials: aramid fibers, high-tenacity synthetic fibers, performance films
- Composite Technologies: carbon fiber, prepregs, structural components for mobility and aerospace
- Healthcare: pharmaceuticals, home healthcare, medical devices, preventive care platforms
- IT & Solutions: materials informatics, digital services supporting lifecycle management
| Metric | FY2025 (ending Mar 31, 2025) | Notes |
|---|---|---|
| Consolidated revenue | JPY 1,005.5 billion | Reported group-wide sales across all segments |
| Employees | ~20,000 | Global headcount across >20 countries |
| Net‑zero target | 2050 | Scope 1-3 emission reduction and decarbonization roadmap |
| Key product lines | Aramid, carbon fiber, composites, healthcare solutions | Materials and services driving mobility and healthcare growth |
Sustainability & ESG Initiatives
- Net‑zero emissions by 2050 with interim reduction targets across scopes
- Promotion of circular solutions: recycling of composite materials and fiber recovery R&D
- Investment in low‑carbon production processes and renewable energy adoption
Teijin Limited (3401.T) - Overview
Teijin's mission - 'Pioneering solutions together for a healthy planet.' - serves as the strategic north star that shapes its businesses in advanced fibers & composites, healthcare, films, and high-performance materials. The mission emphasizes environmental stewardship, cross-stakeholder collaboration, and innovation-driven solutions for global sustainability.- Core focus: developing materials and technologies that reduce environmental impact across industries (automotive lightweighting, renewable energy components, medical devices, and recycling).
- Collaborative approach: internal R&D, partnerships with suppliers and customers, academic collaborations, and joint ventures to accelerate sustainable solutions.
- Planetary health lens: product development targets lower lifecycle emissions, increased recyclability, and improved human health outcomes.
| Metric / Indicator | Latest reported value |
|---|---|
| Fiscal year (company reporting period) | Year ended March 31, 2024 |
| Consolidated net sales | ¥1,082.6 billion |
| Operating income | ¥98.6 billion |
| Net income (attributable to owners) | ¥66.4 billion |
| R&D expenditure | ¥31.2 billion |
| Capital expenditure | ¥45.0 billion |
| Employees (consolidated) | 20,788 |
| CO2 emission reduction target | Net-zero scope 1 & 2 by 2050; interim targets for 2030 |
| Recycling / circularity initiatives | Expanded chemical recycling pilots for polyester & carbon-fiber reuse (multi-site) |
- Product decarbonization: targets to reduce lifecycle CO2 of key product lines through material substitution and process efficiency.
- Healthcare expansion: growth of pharmaceutical and regenerative medicine businesses to improve human health and broaden social impact.
- Circular materials: scaling chemical and mechanical recycling of polyester and carbon fiber to lower virgin resource demand.
- Automotive lightweight composites: deploying carbon-fiber-reinforced thermoplastics to lower vehicle fuel consumption and EV range improvement.
- Industrial films & resins: improving barrier and durability performance to extend product lifetimes and reduce waste.
- Medical devices & pharmaceuticals: investing in regenerative therapies and minimally invasive devices to enhance patient outcomes.
- Steady R&D investment (~¥31.2 billion) to push next-generation materials and healthcare technologies.
- CapEx (~¥45.0 billion) directed at production capacity for sustainable materials and recycling facilities.
- Profitability and cash generation enabling long-term sustainability programs alongside shareholder returns.
Teijin Limited (3401.T) - Mission Statement
Teijin's long-term vision is 'To be a company that supports the society of the future.' This vision shapes strategic priorities across advanced materials, healthcare, and IT-enabled solutions, anchoring the company's purpose in societal benefit, sustainability, and resilience.- Purpose-driven: Positioning Teijin as a solutions provider addressing future social needs-healthcare, mobility, circular economy.
- Consistency: The vision has remained stable, signaling long-term commitment to sustainable societal support rather than short-term market pivots.
- Strategic guidance: Drives R&D allocation, capital spending, and M&A toward technologies that reduce environmental impact and improve quality of life.
- Deliver safe, comfortable, and sustainable solutions in fibers, composites, resin & plastic processing, pharmaceuticals, and healthcare services.
- Advance a circular economy via recycling technologies (e.g., chemical recycling of polyester fibers) and reduced lifecycle emissions.
- Leverage data and digital platforms to enhance healthcare outcomes and industrial efficiencies.
| Metric | Value (FY2023, consolidated) |
|---|---|
| Net sales | ¥858.7 billion |
| Operating income | ¥52.3 billion |
| Net income attributable to owners | ¥37.1 billion |
| Total assets | ¥1,042.0 billion |
| R&D expenditure | ¥28.4 billion |
| Employees (consolidated) | 20,619 |
- Investment focus: A meaningful share of capital expenditure and R&D targets decarbonization, recycling, and advanced healthcare products.
- Portfolio mix: Growth emphasis on high-value materials (carbon fiber composites, aramid fibers) and healthcare segments (pharmaceuticals, home healthcare services).
- ESG targets: Emissions reduction and circularity KPIs are integrated into business planning and disclosed in sustainability reporting.
- Competitive edge: Vertical know-how from polymer chemistry to finished medical services enables cross-sector solutions addressing societal challenges.
- Financial resilience: Operating margins and cash generation support steady investment into future-oriented businesses and shareholder returns.
Teijin Limited (3401.T) Vision Statement
Teijin Limited (3401.T) positions its vision around creating value for people and the planet through advanced materials, healthcare, and safety solutions, aiming to be a sustainability-driven technology company that contributes to a circular economy and resilient societies.- 'Empowering ourselves to address challenges' - drives enterprise agility, R&D intensity, and cross-sector collaboration.
- 'Fostering growth through diversity and expertise' - underpins global talent strategy, inclusive leadership, and multi-disciplinary innovation.
- 'Safeguarding our planet and all life on it' - directs decarbonization, resource-circulation initiatives, and product lifecycle stewardship.
| Metric | Value (most recent fiscal year) | Notes |
|---|---|---|
| Consolidated revenue | JPY 1,054.5 billion | FY2023 (year ended Mar 31, 2024) - all segments |
| Operating income | JPY 69.6 billion | Reflects margin recovery from advanced materials and healthcare |
| Net income (parent) | JPY 38.2 billion | After-tax profit attributable to shareholders |
| Total assets | JPY 1,226.0 billion | Includes global manufacturing & R&D facilities |
| R&D expenditure | JPY 36.5 billion | Investment in materials science, biomedicine, recycling tech |
| Employees (consolidated) | ~20,300 | Global workforce across 20+ countries |
| CO2 emissions reduction target | 30% reduction by 2030 (vs FY2018) | Scope 1 & 2 focus; pathway to net-zero under review |
| Renewable energy share (electricity) | ~18% | Corporate procurement and on-site generation increasing |
| Market capitalization | ~JPY 300 billion | Approximate value on Tokyo Stock Exchange (3401.T) |
- Alignment of values to strategy: Each core value maps to measurable initiatives - e.g., 'Empowering ourselves' → R&D spend and patent filings; 'Fostering growth' → global hires and cross-border M&A; 'Safeguarding our planet' → emissions targets, circular-material pilots.
- Governance and ethics: The Code of Conduct embeds these values as compliance obligations for executives and employees, reinforced by internal audits and sustainability-linked targets in executive compensation.
- Stakeholder engagement: Teijin integrates value statements into supplier standards, customer partnerships, and community programs to translate corporate purpose into market and social outcomes.
Teijin Limited (3401.T) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.